ARTICLE SUMMARY:
All the major electrophysiology competitors are developing pulsed field ablation technologies to make treatment of cardiac arrhythmia safer and efficient. PFA is rapidly growing the overall electrophysiology market and every company developing a PFA system insists theirs offers unique advantages.
Pulsed field ablation (PFA) is set to supplant radiofrequency (RF) and cryoablation as the preferred catheter-based approach to stopping arrhythmias. Because it is safer and faster than older technologies, it is helping electrophysiologists treat more patients and accelerate the overall growth of the cardiac ablation business.
